TEM on XNAS, Technology, Tempus AI, Inc., job postings
Measures activity, not value. Not investment advice.
Revenue rose 37% to $1.5B, but the company lost money while insiders sold $78M in 90 days.
BadFree cash flow was -$136.8M over 12 months
GoodFederal contracts and grants $29.1M over 12 months, up from $5.8M
Written by AI from the data on this page, 21 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Industry
Services-computer programming, data processing, etc. (Technology)
expected around 11 Jan 2027 (an estimate: a year ago it reported on 12 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $411.5M, net loss $14.9M.
30 Jun 2023RevenueNet incomeNet losstallest bar $552.2M30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$411.5M
-$14.9M
30 Jun 2026
$382.5M
$5.6M
31 Mar 2026
$348.1M
-$125.9M
31 Dec 2025
$367.2M
-$54.2M
30 Sep 2025
$334.2M
-$80.0M
30 Jun 2025
$314.6M
-$42.8M
31 Mar 2025
$255.7M
-$68.0M
31 Dec 2024
$200.7M
-$13.0M
30 Sep 2024
$180.9M
-$75.8M
30 Jun 2024
$166.0M
-$552.2M
31 Mar 2024
$145.8M
-$64.7M
31 Dec 2023
$147.7M
-$50.5M
30 Sep 2023
$136.1M
-$53.4M
30 Jun 2023
$132.4M
-$55.8M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$1.5B
$1.1B
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+37%
+7.2%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
-$189.3M
-$203.9M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
-$1.07
-$0.30
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
–
–
61.3%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
-18.5%
-21.9%
-2.5%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
-12.5%
-18.4%
-5.4%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
-37.5%
-6.8%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
-$136.8M
-$244.8M
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$590.5M
$655.9M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$176.0M
$518.8M
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
-$414.5M (net cash)
-$137.1M
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
0.35
0.32
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
–
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
loss
20.1
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
6.5
1.3
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
6.3
1.5
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
19.7
1.9
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
-$78.0M
bought $0, sold $78.0M
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+15%
550 13F filers vs 478
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
–
No 13F holdings or share count.
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
–
24.5M shares sold short (30 Oct 2026); no share count in the company's filings in our data
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
4.5
24.5M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
-3.3%
25.4M shares sold short in the report before, 24.5M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
56%
56% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 51%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
–
We do not track this company's careers site yet.
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
We do not track this company's careers site yet.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
-29%
55 vs 77 applications
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+23%
$411.5M vs $334.2M (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
+39%
$9.3M vs $6.7M (quarter ended 30 Sep 2026)
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
$29.1M
the 12 months before: $5.8M
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
$320K
4 quarters, $
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
78
78 articles in the last 7 days; its usual week has 9 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
8.7×
78 articles in the last 7 days; its usual week has 9.
Unusual now sharp changes in the last 90 days, compared with its own past
Federal obligations $11.6M, -8.7% vs a year earlier
Lobbying spend $140K, 2.3× a year earlier
Price $54.04 on 20 Nov 2026, -18% over 12 months (12-month range $41.55 to $85.08)
Sharp change
8-K and other filings
Lobbying filing
Insider net buying (open market). Insiders sold a net $182.8M in the last 12 months (the 12 months before: -$740.2M).H-1B/E-3 applications certified. H-1B/E-3 applications certified: 55 published in the last 12 months, -29% on the 12 months before.Revenue per quarter. Revenue $411.5M in the latest quarter, +23% on a year earlier.Capital spending per quarter. Capital spending $9.3M in the latest quarter, +39% on a year earlier.Institutional holders (13F filers). 550 13F filers reported holding it in the latest 13F quarter, +33% on a year earlier.Federal obligations. Federal obligations: $30.5M published in the last 12 months, +65% on the 12 months before.Lobbying spend. Lobbying spend: $320K published in the last 12 months, +78% on the 12 months before.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.
Quarter ended 30 Jun 2023: $132.4M; public on 7 Aug 2024
Quarter ended 30 Sep 2023: $136.1M; public on 5 Nov 2024
Quarter ended 31 Dec 2023: $147.7M; public on 25 Feb 2025
Quarter ended 31 Mar 2024: $145.8M; public on 7 May 2025
Quarter ended 30 Jun 2024: $166.0M, +25% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $180.9M, +33% on a year earlier; public on 5 Nov 2024
Quarter ended 31 Dec 2024: $200.7M, +36% on a year earlier; public on 25 Feb 2025
Quarter ended 31 Mar 2025: $255.7M, +75% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $314.6M, +90% on a year earlier; public on 9 Aug 2025
Quarter ended 30 Sep 2025: $334.2M, +85% on a year earlier; public on 5 Nov 2025
Quarter ended 31 Dec 2025: $367.2M, +83% on a year earlier; public on 25 Feb 2026
Quarter ended 31 Mar 2026: $348.1M, +36% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $382.5M, +22% on a year earlier; public on 31 Jul 2026
Quarter ended 30 Sep 2026: $411.5M, +23% on a year earlier; public on 3 Nov 2026
Capital spending per quarter
Quarter ended 30 Sep 2023: $16.0M; public on 5 Nov 2024
Quarter ended 31 Dec 2023: $2.7M; public on 25 Feb 2025
Quarter ended 31 Mar 2024: $6.1M; public on 7 May 2025
Quarter ended 30 Jun 2024: $8.0M; public on 7 Aug 2024
Quarter ended 31 Dec 2024: $8.0M, +194% on a year earlier; public on 25 Feb 2025
Quarter ended 31 Mar 2025: $2.1M, -66% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $7.5M, -6.2% on a year earlier; public on 9 Aug 2025
Quarter ended 30 Sep 2025: $6.7M; public on 5 Nov 2025
Quarter ended 31 Dec 2025: $4.8M, -40% on a year earlier; public on 25 Feb 2026
Quarter ended 31 Mar 2026: $8.2M, +295% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $6.1M, -18% on a year earlier; public on 31 Jul 2026
Quarter ended 30 Sep 2026: $9.3M, +39% on a year earlier; public on 3 Nov 2026
Institutional holders (13F filers)
30 Jun 2024 report: 76; public on 14 Aug 2024
30 Sep 2024 report: 91; public on 14 Nov 2024
31 Dec 2024 report: 153; public on 14 Feb 2025
31 Mar 2025 report: 275; public on 15 May 2025
30 Jun 2025 report: 351; public on 14 Aug 2025
30 Sep 2025 report: 415; public on 14 Nov 2025
31 Dec 2025 report: 430; public on 17 Feb 2026
31 Mar 2026 report: 417; public on 15 May 2026
30 Jun 2026 report: 478; public on 14 Aug 2026
30 Sep 2026 report: 550; public on 16 Nov 2026
Federal obligations
Month from 1 Feb 2022: $4.0M published
Month from 1 Apr 2022: $0 published
Month from 1 Jun 2022: $0 published
Month from 1 Aug 2022: $135K published
Month from 1 Oct 2022: $325K published
Month from 1 Jan 2023: -$489K published
Month from 1 Feb 2023: $1.5M published
Month from 1 Mar 2023: -$24K published
Month from 1 Jun 2023: $2.4M published
Month from 1 Jul 2023: -$2.0M published
Month from 1 Dec 2023: $4.1M published
Month from 1 Feb 2024: $6.0M published
Month from 1 May 2024: -$130K published
Month from 1 Oct 2024: $68K published
Month from 1 Feb 2025: $5.7M published
Month from 1 Mar 2025: $0 published
Month from 1 Sep 2025: $12.7M published
Month from 1 Feb 2026: $8.0M published
Month from 1 Mar 2026: -$3K published
Month from 1 Apr 2026: $0 published
Month from 1 Jul 2026: $8.4M published
Month from 1 Sep 2026: $14.1M published
Month from 1 Nov 2026: $0 published
Lobbying spend
Quarter from 1 Jan 2022: $50K published
Quarter from 1 Apr 2022: $70K published
Quarter from 1 Jul 2022: $80K published
Quarter from 1 Oct 2022: $80K published
Quarter from 1 Jan 2023: $80K published
Quarter from 1 Apr 2023: $90K published
Quarter from 1 Jul 2023: $80K published
Quarter from 1 Oct 2023: $75K published
Quarter from 1 Jan 2024: $180K published
Quarter from 1 Apr 2025: $60K published
Quarter from 1 Jul 2025: $60K published
Quarter from 1 Oct 2025: $60K published
Quarter from 1 Jan 2026: $60K published
Quarter from 1 Apr 2026: $60K published
Quarter from 1 Jul 2026: $60K published
Quarter from 1 Oct 2026: $140K published
What is unusual now
Made public in the last 90 days: it booked $11.6M in federal contract and grant obligations in September 2026, 8.7% below the same month last year; it also reported $140K of lobbying spend for the quarter ended 30 Sep 2026, 2.3× the same quarter last year.
Federal obligations jump: booked $11.6M in federal contract and grant obligations in September 2026, 8.7% below the same month last year Public on 21 Sep 2026.
Short interest spike: had 35.2M shares sold short in the 15 May 2026 report, 1.7× the same report last year Public on 28 May 2026.
Reported lobbying spend: $140K in Q3 2026, $60K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
General issues related to Artificial Intelligence in healthcare. General Issues related to healthcare data privacy and security.; CY 2024 Clinical Lab Fee Schedule Preliminary Determinations on Genomic Sequencing Procedure Codes; Transitional Coverage for Emerging Technologies; Precision medicine; General legislation on AI in healthcare; Data Privacy; Artificial Intelligence/Machine Learning in healthcare. Reimbursement for AI in healthcare. Increasing multi-modal data in medical research and innovation. Advancing acceptance of Real World Data and Real World Evidence. Diversifying clinical trials through data and technology.; Access and reimbursement to advanced genomic testing for cancer; Artificial Intelligence in healthcare; Increasing overall access to and diversity of clinical trials. Advancing Real World Data and Real World Evidence in research and development.Health issues, Medicare/Medicaid, Science/technology, MED
Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.Health issues, MED, Science/technology
Two or more unrelated kinds of records unusual within 30 days
6 Nov 2025confirmed
Confirmed across sources Government contracts and Filings + Financials
Tempus AI(TEM): booked $12.7M in federal contract and grant obligations in September 2025, 189× the same month last year, while it reported revenue of $334.2M for the quarter ended 30 Sep 2025, 1.8× the same quarter last year. Two unrelated kinds of activity within 30 days.
Government contracts: Federal obligations jump, became public on 23 Sep 2025
Financials: Quarterly revenue change, became public on 6 Nov 2025
September 2025 against the 5 months before it.
this monthearliernormal: $0See the evidence (2 changes)
Government contracts: Federal obligations jump became public on 23 Sep 2025
Tempus AI booked $12.7M in federal contract and grant obligations in September 2025, 189× the same month last year.
This period
$12.7M (September 2025)
Normal month (median of 5 earlier)
$0
Typical spread (median absolute deviation)
$0
How far from its usual level
+12.7
Same month last year
$68K
History used
2,790 days
September 20255 earlier monthsnormal: $0
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
Financials: Quarterly revenue change became public on 6 Nov 2025
Tempus AI reported revenue of $334.2M for the quarter ended 30 Sep 2025, 1.8× the same quarter last year.
This period
$334.2M (the quarter ended 30 Sep 2025)
Normal quarter (median of 8 earlier)
$173.4M
Typical spread (median absolute deviation)
$27.4M
How far from its usual level
+4.0
Same quarter last year
$180.9M
History used
823 days
the quarter ended 30 Sep 20258 earlier quartersnormal: $173.4M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
6 Feb 2024confirmed
Confirmed across sources Government contracts and Lobbying
Tempus AI(TEM): reported $180K of lobbying spend for the quarter ended 31 Dec 2023, 2.2× the same quarter last year, while it booked $6.0M in federal contract and grant obligations in January 2024, 4.1× the same month last year. Two unrelated kinds of activity within 14 days.
Lobbying: Lobbying spend jump, became public on 22 Jan 2024
Government contracts: Federal obligations jump, became public on 1 Feb 2024
The quarter ended 31 Dec 2023 against the 8 quarters before it.
this quarterearliernormal: $80KSee the evidence (2 changes)
Lobbying: Lobbying spend jump became public on 22 Jan 2024
Tempus AI reported $180K of lobbying spend for the quarter ended 31 Dec 2023, 2.2× the same quarter last year.
This period
$180K (the quarter ended 31 Dec 2023)
Normal quarter (median of 8 earlier)
$80K
Typical spread (median absolute deviation)
$2K
How far from its usual level
+5.0
Same quarter last year
$80K
History used
730 days
the quarter ended 31 Dec 20238 earlier quartersnormal: $80K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
Government contracts: Federal obligations jump became public on 1 Feb 2024
Tempus AI booked $6.0M in federal contract and grant obligations in January 2024, 4.1× the same month last year.
This period
$6.0M (January 2024)
Normal month (median of 5 earlier)
$377K
Typical spread (median absolute deviation)
$377K
How far from its usual level
+5.6
Same month last year
$1.5M
History used
2,182 days
January 20245 earlier monthsnormal: $377K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
Timeline
Changes and notable records, by the date each became public
15 Oct 2026Lobbying change
reported $140K of lobbying spend for the quarter ended 30 Sep 2026, 2.3× the same quarter last year.
Same quarter last year: $60K; its normal quarter is $60K.
See the evidence
This period
$140K (the quarter ended 30 Sep 2026)
Normal quarter (median of 7 earlier)
$60K
Typical spread (median absolute deviation)
$0
How far from its usual level
+4.0
Same quarter last year
$60K
History used
1,734 days
the quarter ended 30 Sep 20267 earlier quartersnormal: $60K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
booked $11.6M in federal contract and grant obligations in September 2026, 8.7% below the same month last year.
Same month last year: $12.7M; its normal month is $68K.
See the evidence
This period
$11.6M (September 2026)
Normal month (median of 5 earlier)
$68K
Typical spread (median absolute deviation)
$68K
How far from its usual level
+11.6
Same month last year
$12.7M
History used
3,155 days
September 20265 earlier monthsnormal: $68K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
booked $8.4M in federal contract and grant obligations in June 2026, against none in the same month last year.
See the evidence
This period
$8.4M (June 2026)
Normal month (median of 5 earlier)
$0
Typical spread (median absolute deviation)
$0
How far from its usual level
+8.4
Same month last year
$0
History used
3,063 days
June 20265 earlier monthsnormal: $0
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
had 35.2M shares sold short in the 15 May 2026 report, 1.7× the same report last year.
Same report last year: 21.1M; its normal report is 22.5M.
See the evidence
This period
35.2M (the 15 May 2026 report)
Normal report (median of 24 earlier)
22.5M
Typical spread (median absolute deviation)
1.5M
How far from its usual level
+5.6
Same report last year
21.1M
History used
686 days
the 15 May 2026 report24 earlier reportsnormal: 22.5M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
booked $12.7M in federal contract and grant obligations in September 2025, 189× the same month last year, while it reported revenue of $334.2M for the quarter ended 30 Sep 2025, 1.8× the same quarter last year. Two unrelated kinds of activity within 30 days.
See the evidence (2 changes)
Government contracts: Federal obligations jump became public on 23 Sep 2025
Tempus AI booked $12.7M in federal contract and grant obligations in September 2025, 189× the same month last year.
This period
$12.7M (September 2025)
Normal month (median of 5 earlier)
$0
Typical spread (median absolute deviation)
$0
How far from its usual level
+12.7
Same month last year
$68K
History used
2,790 days
September 20255 earlier monthsnormal: $0
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
Financials: Quarterly revenue change became public on 6 Nov 2025
Tempus AI reported revenue of $334.2M for the quarter ended 30 Sep 2025, 1.8× the same quarter last year.
This period
$334.2M (the quarter ended 30 Sep 2025)
Normal quarter (median of 8 earlier)
$173.4M
Typical spread (median absolute deviation)
$27.4M
How far from its usual level
+4.0
Same quarter last year
$180.9M
History used
823 days
the quarter ended 30 Sep 20258 earlier quartersnormal: $173.4M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
6 Nov 2025Financials change
reported revenue of $334.2M for the quarter ended 30 Sep 2025, 1.8× the same quarter last year.
Same quarter last year: $180.9M; its normal quarter is $173.4M.
See the evidence
This period
$334.2M (the quarter ended 30 Sep 2025)
Normal quarter (median of 8 earlier)
$173.4M
Typical spread (median absolute deviation)
$27.4M
How far from its usual level
+4.0
Same quarter last year
$180.9M
History used
823 days
the quarter ended 30 Sep 20258 earlier quartersnormal: $173.4M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
booked $12.7M in federal contract and grant obligations in September 2025, 189× the same month last year.
Same month last year: $68K; its normal month is $0.
See the evidence
This period
$12.7M (September 2025)
Normal month (median of 5 earlier)
$0
Typical spread (median absolute deviation)
$0
How far from its usual level
+12.7
Same month last year
$68K
History used
2,790 days
September 20255 earlier monthsnormal: $0
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
reported revenue of $314.6M for the quarter ended 30 Jun 2025, 1.9× the same quarter last year.
Same quarter last year: $166.0M; its normal quarter is $156.8M.
See the evidence
This period
$314.6M (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
$156.8M
Typical spread (median absolute deviation)
$22.4M
How far from its usual level
+4.7
Same quarter last year
$166.0M
History used
731 days
the quarter ended 30 Jun 20258 earlier quartersnormal: $156.8M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
reported revenue of $255.7M for the quarter ended 31 Mar 2025, 1.8× the same quarter last year.
Same quarter last year: $145.8M; its normal quarter is $147.7M.
See the evidence
This period
$255.7M (the quarter ended 31 Mar 2025)
Normal quarter (median of 7 earlier)
$147.7M
Typical spread (median absolute deviation)
$15.3M
How far from its usual level
+4.8
Same quarter last year
$145.8M
History used
640 days
the quarter ended 31 Mar 20257 earlier quartersnormal: $147.7M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
reported $180K of lobbying spend for the quarter ended 31 Dec 2023, 2.2× the same quarter last year, while it booked $6.0M in federal contract and grant obligations in January 2024, 4.1× the same month last year. Two unrelated kinds of activity within 14 days.
See the evidence (2 changes)
Lobbying: Lobbying spend jump became public on 22 Jan 2024
Tempus AI reported $180K of lobbying spend for the quarter ended 31 Dec 2023, 2.2× the same quarter last year.
This period
$180K (the quarter ended 31 Dec 2023)
Normal quarter (median of 8 earlier)
$80K
Typical spread (median absolute deviation)
$2K
How far from its usual level
+5.0
Same quarter last year
$80K
History used
730 days
the quarter ended 31 Dec 20238 earlier quartersnormal: $80K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
Government contracts: Federal obligations jump became public on 1 Feb 2024
Tempus AI booked $6.0M in federal contract and grant obligations in January 2024, 4.1× the same month last year.
This period
$6.0M (January 2024)
Normal month (median of 5 earlier)
$377K
Typical spread (median absolute deviation)
$377K
How far from its usual level
+5.6
Same month last year
$1.5M
History used
2,182 days
January 20245 earlier monthsnormal: $377K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
1 Feb 2024Government contracts change
booked $6.0M in federal contract and grant obligations in January 2024, 4.1× the same month last year.
Same month last year: $1.5M; its normal month is $377K.
See the evidence
This period
$6.0M (January 2024)
Normal month (median of 5 earlier)
$377K
Typical spread (median absolute deviation)
$377K
How far from its usual level
+5.6
Same month last year
$1.5M
History used
2,182 days
January 20245 earlier monthsnormal: $377K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
reported $180K of lobbying spend for the quarter ended 31 Dec 2023, 2.2× the same quarter last year.
Same quarter last year: $80K; its normal quarter is $80K.
See the evidence
This period
$180K (the quarter ended 31 Dec 2023)
Normal quarter (median of 8 earlier)
$80K
Typical spread (median absolute deviation)
$2K
How far from its usual level
+5.0
Same quarter last year
$80K
History used
730 days
the quarter ended 31 Dec 20238 earlier quartersnormal: $80K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
Not listed: 204 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001717115
Ticker
TEM
Domain
tempus.com
Employer name
Ambry Genetics Corporation, Tempus AI, Tempus Labs, Inc. (3 unverified)
Fein
33-0892453, 47-4903308 (2 unverified)
Hq location
IL|CHICAGO|60654 (1 unverified)
Lobbying client
tempus ai, tempus labs
Name
Ambry Genetics Corporation, Arterys Inc, Deep 6 AI, Inc, Genome Smart Inc and 14 more
Uei
PW4TQZ3KDLU3
Wikipedia
Tempus AI
DOL H-1B labor condition applications and PERM certifications438 data points8 Jan 2024 to 28 Sep 2026
Federal lobbying disclosures (LDA)6 records, 48 data points4 Oct 2021 to 30 Sep 2026
SEC Form 13F institutional holdings1 record, 90 data points30 Jun 2024 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)44 records25 Sep 2017 to 18 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)211 data points31 Dec 2021 to 30 Sep 2026
SEC Form 4 insider transactions169 records, 328 data points12 Dec 2024 to 19 Nov 2026
FINRA short interest (twice monthly)170 data points28 Jun 2024 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)1224 data points14 Jun 2024 to 20 Nov 2026
USASpending.gov federal awards9 records, 135 data points9 Feb 2018 to 2 Nov 2026
Wikipedia pageviews10 data points11 Nov 2026 to 20 Nov 2026